Cancer Research Institute is a New York-based nonprofit foundation that deploys donor capital into cancer immunotherapy research, fellowships, clinical trials, translational programs and strategic partnerships. For fundraising relevance, it has also participated in U.S. biotechnology, oncology and life sciences company financings across seed, early-stage and later-stage VC rounds, with a focus on cancer immunotherapy, gene therapy, precision medicine and related therapeutic platforms. The organization reports more than $570M invested in immunotherapy research since 1953 and operates with a United States and global mandate.